Form 4: Nanophase Technologies Director Janet Whitmore Acquires Additional Shares
SEC Form 4
Director Janet Whitmore of Nanophase Technologies Corp. reports purchasing shares of common stock in two transactions on September 19, 2024.
Summary
- On September 19, 2024, Janet Whitmore, a director at Nanophase Technologies Corp. (NANX), purchased 200 shares of common stock at $1.57 per share.
- Whitmore also purchased 2,000 shares of common stock at $1.56 per share on the same day.
- Following these transactions, Whitmore directly owns 1,953,909 shares of Nanophase Technologies Corp.
- Whitmore also holds deferred common stock and options to purchase additional shares at various exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The director's purchase of shares is a positive sign, but the amount is relatively small. The existence of stock options suggests a long-term incentive structure.
Positives
- Director's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into insider transactions. These filings are closely watched by investors as they can provide insights into management's perspective on the company's valuation and future prospects.
Comparison to Industry Standards
- Comparing Janet Whitmore's transactions to other directors' purchases in similar nanotechnology companies is difficult without specific data on those transactions.
- Generally, insider buying is seen as a positive signal, but the significance depends on the size of the purchase relative to the insider's existing holdings and the company's market capitalization.
- For example, if another director at a similar company like US Nanocorp purchased a significantly larger amount of shares, it could be seen as a stronger signal of confidence.
Stakeholder Impact
- The director's purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 11/17/2016 | Date of grant for several stock appreciation rights (later converted to options) with various exercise prices, expiring on 11/17/2026. |
| 02/21/2018 | Date of grant for stock options with an exercise price of $0.68, expiring on 02/21/2027. |
| 05/23/2019 | Date of grant for stock options with an exercise price of $0.82, expiring on 05/23/2028. |
| 06/18/2021 | Date of grant for stock options with an exercise price of $0.45, expiring on 06/18/2027. |
| 12/28/2022 | Date of grant for stock options with an exercise price of $4.17, expiring on 12/28/2028. |
| 12/20/2023 | Date of grant for stock options with an exercise price of $1.165, expiring on 12/20/2029. |
| 09/19/2024 | Date of Janet Whitmore's purchase of 200 shares at $1.57 and 2,000 shares at $1.56. |
| 12/27/2024 | Date of grant for stock options with an exercise price of $0.61, expiring on 12/27/2030. |
| 09/23/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.